Literature DB >> 16598496

High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening.

P J O'Brien1, W Irwin, D Diaz, E Howard-Cofield, C M Krejsa, M R Slaughter, B Gao, N Kaludercic, A Angeline, P Bernardi, P Brain, C Hougham.   

Abstract

To develop and validate a practical, in vitro, cell-based model to assess human hepatotoxicity potential of drugs, we used the new technology of high content screening (HCS) and a novel combination of critical model features, including (1) use of live, human hepatocytes with drug metabolism capability, (2) preincubation of cells for 3 days with drugs at a range of concentrations up to at least 30 times the efficacious concentration or 100 microM, (3) measurement of multiple parameters that were (4) morphological and biochemical, (5) indicative of prelethal cytotoxic effects, (6) representative of different mechanisms of toxicity, (7) at the single cell level and (8) amenable to rapid throughput. HCS is based on automated epifluorescence microscopy and image analysis of cells in a microtiter plate format. The assay was applied to HepG2 human hepatocytes cultured in 96-well plates and loaded with four fluorescent dyes for: calcium (Fluo-4 AM), mitochondrial membrane potential (TMRM), DNA content (Hoechst 33,342) to determine nuclear area and cell number and plasma membrane permeability (TOTO-3). Assay results were compared with those from 7 conventional, in vitro cytotoxicity assays that were applied to 611 compounds and shown to have low sensitivity (<25%), although high specificity ( approximately 90%) for detection of toxic drugs. For 243 drugs with varying degrees of toxicity, the HCS, sublethal, cytotoxicity assay had a sensitivity of 93% and specificity of 98%. Drugs testing positive that did not cause hepatotoxicity produced other serious, human organ toxicities. For 201 positive assay results, 86% drugs affected cell number, 70% affected nuclear area and mitochondrial membrane potential and 45% affected membrane permeability and 41% intracellular calcium concentration. Cell number was the first parameter affected for 56% of these drugs, nuclear area for 34% and mitochondrial membrane potential for 29% and membrane permeability for 7% and intracellular calcium for 10%. Hormesis occurred for 48% of all drugs with positive response, for 26% of mitochondrial and 34% nuclear area changes and 12% of cell number changes. Pattern of change was dependent on the class of drug and mechanism of toxicity. The ratio of concentrations for in vitro cytotoxicity to maximal efficaciousness in humans was not different across groups (12+/-22). Human toxicity potential was detected with 80% sensitivity and 90% specificity at a concentration of 30x the maximal efficacious concentration or 100 microM when efficaciousness was not considered. We conclude that human hepatotoxicity is highly concordant with in vitro cytotoxicity in this novel model and as detected by HCS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16598496     DOI: 10.1007/s00204-006-0091-3

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  108 in total

1.  Translational research: current status, challenges and future strategies.

Authors:  Dale Yu
Journal:  Am J Transl Res       Date:  2011-09-12       Impact factor: 4.060

2.  High-content assays for hepatotoxicity using induced pluripotent stem cell-derived cells.

Authors:  Oksana Sirenko; Jayne Hesley; Ivan Rusyn; Evan F Cromwell
Journal:  Assay Drug Dev Technol       Date:  2013-11-14       Impact factor: 1.738

3.  High-Content Analysis Provides Mechanistic Insights into the Testicular Toxicity of Bisphenol A and Selected Analogues in Mouse Spermatogonial Cells.

Authors:  Shenxuan Liang; Lei Yin; Kevin Shengyang Yu; Marie-Claude Hofmann; Xiaozhong Yu
Journal:  Toxicol Sci       Date:  2016-09-14       Impact factor: 4.849

4.  Acute ethanol preexposure promotes liver regeneration after partial hepatectomy in mice by activating ALDH2.

Authors:  Xiang Ding; Juliane I Beier; Keegan J Baldauf; Jenny D Jokinen; Hai Zhong; Gavin E Arteel
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-10-31       Impact factor: 4.052

Review 5.  In vitro platforms for evaluating liver toxicity.

Authors:  Shyam Sundhar Bale; Lawrence Vernetti; Nina Senutovitch; Rohit Jindal; Manjunath Hegde; Albert Gough; William J McCarty; Ahmet Bakan; Abhinav Bhushan; Tong Ying Shun; Inna Golberg; Richard DeBiasio; Berk Osman Usta; D Lansing Taylor; Martin L Yarmush
Journal:  Exp Biol Med (Maywood)       Date:  2014-04-24

Review 6.  The Promise of AI for DILI Prediction.

Authors:  Andreu Vall; Yogesh Sabnis; Jiye Shi; Reiner Class; Sepp Hochreiter; Günter Klambauer
Journal:  Front Artif Intell       Date:  2021-04-14

7.  Mitochondrial dysfunction and apoptosis underlie the hepatotoxicity of perhexiline.

Authors:  Zhen Ren; Si Chen; Ji-Eun Seo; Xiaoqing Guo; Dongying Li; Baitang Ning; Lei Guo
Journal:  Toxicol In Vitro       Date:  2020-08-28       Impact factor: 3.500

8.  Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.

Authors:  Denis Fourches; Julie C Barnes; Nicola C Day; Paul Bradley; Jane Z Reed; Alexander Tropsha
Journal:  Chem Res Toxicol       Date:  2010-01       Impact factor: 3.739

9.  Synergistic metabolic toxicity screening using microsome/DNA electrochemiluminescent arrays and nanoreactors.

Authors:  Sadagopan Krishnan; Eli G Hvastkovs; Besnik Bajrami; Dharamainder Choudhary; John B Schenkman; James F Rusling
Journal:  Anal Chem       Date:  2008-06-19       Impact factor: 6.986

10.  Characterization of diversity in toxicity mechanism using in vitro cytotoxicity assays in quantitative high throughput screening.

Authors:  Ruili Huang; Noel Southall; Ming-Hsuang Cho; Menghang Xia; James Inglese; Christopher P Austin
Journal:  Chem Res Toxicol       Date:  2008-02-19       Impact factor: 3.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.